ALB and hereditary elliptocytosis: The study reported risk factors for HE development including higher bilirubin and nonselective beta-blocker use, while higher albumin and statin use were found to be protective.13 Model effects were validated and converted into a risk score by summing risk points accumulated by each risk factor (beta-blocker use, statin use, total bilirubin, and albumin).